Novartis returns to sales growth in Q2 as newer medicines offset generic pressure (NVS)
Researcher with pipette ©National Institutes of Health New therapies drive quarterly revenue increase Novartis AG (NYSE:NVS) reported higher…
Novartis Reshapes Growth With Biotech Deals And AI Powered R&D Push
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
Novartis Faces Sales and Profit Decline Amid Entresto Generic Competition, ETPharma
London: Swiss drugmaker Novartis reported first-quarter core operating profit and sales below market expectations on Tuesday, as generic…